NasdaqGS - Nasdaq Real Time Price USD
Genfit S.A. (GNFT)
3.6900
-0.0800
(-2.12%)
As of 1:19:02 PM EDT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-55,429
-55,429
-72,638
99,915
-96,371
Investing Cash Flow
2,234
2,234
-46,266
-3,377
-966
Financing Cash Flow
-5,098
-5,098
-3,786
-8,916
-8,256
End Cash Position
77,789
77,789
136,001
258,756
171,029
Capital Expenditure
-2,488
-2,488
--
-537
-900
Issuance of Capital Stock
--
--
5
27,972
7
Issuance of Debt
89
89
--
15,270
207
Repayment of Debt
-4,694
-4,694
-1,748
-50,323
-2,150
Free Cash Flow
-57,917
-57,917
-72,638
99,378
-97,271
12/31/2020 - 3/27/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ATOS.MX Atossa Therapeutics, Inc.
15.50
+19.23%
AYJ.F Valneva SE
3.1020
-1.27%
AAVXF ABIVAX Société Anonyme
5.81
0.00%
ALCOX.PA Nicox S.A.
0.2260
0.00%
VALN Valneva SE
6.94
+1.02%
PHXM.PA PHAXIAM Therapeutics S.A.
0.5800
-3.01%
EFTR eFFECTOR Therapeutics, Inc.
0.0002
0.00%
CLLS Cellectis S.A.
1.4950
+2.40%
ADXN Addex Therapeutics Ltd
7.60
+4.11%
ABVX.PA ABIVAX Société Anonyme
6.12
+1.32%